Manufacturing

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Complex formulations, personalized medicines, COVID-19 therapies, and sustainability goals are driving innovations in drug packaging.

Injecting Innovation into Drug Packaging

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.

Evaluating Cold-Temperature Packaging Closure Systems

Intensified and distributed manufacturing approaches create flexible, local capacity.

Advanced Manufacturing Technologies Shift Outside the Box

The site, which is set to be operational in three years, will feature disposable technology and advanced technology filling lines to produce 90 million vials and 50 million pre-filled syringes a year. 

Civica to Launch Sterile Injectable Manufacturing Facility in Virginia

The product represents a first-of-its-kind intentional genomic alteration in a line of domestic pigs that may be used for human therapeutics.

FDA Approves First-of-its-Kind Genomically Altered Line of Pigs for Potential Therapeutic Uses

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. 

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity 

Gerresheimer now offers its Gx RTF syringes with SG ITC (Integrated Tip Cap) twist-off closure from Stevanato Group. 

Integrated Seal Caps

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

A holistic approach to validation and quality assurance is essential.

Prepping Fill/Finish Systems to Ensure Quality Output 

Richard Denk is Head Sales Containment at SKAN AG, www.skan.ch, Richard.Denk@skan.ch.

An optimal engineering design is crucial for aseptic operation and cleaning.

Understanding the Impact of Annex 1 on Isolator Design

Tjoapack is investing in fully automated lines, including a PFS line with an initial capacity of 7 million syringes per year and a vial line with an eventual capacity of more than 12 million vials per year.

Manufacturing, Parenterals and Injectables